Online citations, reference lists, and bibliographies.
← Back to Search

Transscleral Drug Delivery To The Retina And Choroid

J. Ambati, A. P. Adamis
Published 2002 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Rapid advances in the molecular pathogenesis of retinal and choroidal disorders have highlighted the urgent need for innovative drug delivery modalities to the loci of pathology. In vitro and in vivo studies suggest that the transscleral route may offer a means to achieve the goal of sustained, targeted drug delivery to the posterior segment. Potentially therapeutic concentrations of macromolecules with retention of bioactivity can be attained in the choroid and retina via minimally invasive transscleral delivery.
This paper references
10.1016/S1357-2725(97)00033-2
Type VIII collagen.
C. Shuttleworth (1997)
10.1001/ARCHOPHT.1943.00880170027002
IONTOPHORETIC INTRODUCTION OF ATROPINE AND SCOPOLAMINE INTO THE RABBIT EYE
L. Sallmann (1943)
10.1016/0168-3659(87)90061-7
Transport across epithelial membranes
E. Cooper (1987)
An improved apparatus for transscleral iontophoresis of gentamicin.
A. Church (1992)
10.1016/S0161-6420(86)33781-3
Iontophoresis of fluorescein into the posterior segment of the rabbit eye.
D. Maurice (1986)
10.3109/02713689308999482
Collagens in the aged human macular sclera.
G. E. Marshall (1993)
AN AUTORADIOGRAPHIC STUDY OF THE PENETRATION OF SUBCONJUNCTIVALLY INJECTED HYDROCORTISONE INTO THE NORMAL AND INFLAMED RABBIT EYE.
H. J. Mccartney (1965)
10.1016/S0161-6420(89)32832-6
Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye.
R. Grossman (1989)
10.1016/S0161-6420(93)31639-8
Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.
J. Lim (1993)
Transscleral iontophoresis of gentamicin in monkeys.
M. Barza (1987)
10.2307/3610347
Conduction of Heat in Solids
H. S. Carslaw. (1947)
10.1001/ARCHOPHT.119.8.1165
Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment.
D. Gaton (2001)
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
I. Ahmed (1985)
10.3109/02713688109001870
The penetration of exogenous prostaglandin and arachidonic acid into, and their distribution within, the mammalian eye.
L. Bito (1981)
10.1001/ARCHOPHT.1984.01040031483028
A fresh look at iontophoresis.
L. Hughes (1984)
10.1159/000310693
Scanning electron-microscopic studies of the collagen architecture of the human sclera--normal and pathological findings.
A. Thale (1996)
10.3109/03008209709160218
Organization of fibrillar collagen in the human and bovine cornea: collagen types V and III.
J. White (1997)
10.1089/JOP.1990.6.313
Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
K. Kao (1990)
10.1016/0014-4835(77)90123-3
Exit sites of uveoscleral flow of aqueous humor in cynomolgus monkey eyes.
H. Inomata (1977)
10.1001/ARCHOPHT.1988.01060140266039
Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.
H. Edelhauser (1988)
10.1089/JOP.1994.10.571
Intravitreal delivery of ganciclovir in rabbits by transscleral iontophoresis.
T. Lam (1994)
10.1016/0014-4835(77)90136-1
Diffusion across the sclera.
D. Maurice (1977)
Increased human scleral permeability with prostaglandin exposure.
J. Kim (2001)
10.1016/S0002-9394(99)00129-4
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
O. Weijtens (1999)
10.1055/S-2008-1057552
Unterlagen zur Entstehungstheorie der Myopie
E. S. Awetissow (1980)
10.1006/EXER.2000.0909
The effect of hydration and matrix composition on solute diffusion in rabbit sclera.
O. Boubriak (2000)
10.1111/j.1755-3768.1985.tb06813.x
Topography of scleral emissaries and sclera‐perforating blood vessels
M. Norn (1985)
10.1089/JOP.1991.7.163
Experimental transscleral iontophoresis of ciprofloxacin.
M. Yoshizumi (1991)
10.1016/S0006-3495(93)81324-9
Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging.
C. Nicholson (1993)
10.1137/1.9781611971972
The Mathematics Of Diffusion
J. Crank (1956)
10.1016/S0161-6420(98)91176-9
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
G. Jaffe (1998)
10.1016/S0161-6420(00)00466-8
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
G. Jaffe (2000)
Iontophoresis of gentamicin into aphakic rabbit eyes. Sustained vitreal levels.
P. H. Fishman (1984)
Fundamentals of Heat and Mass Transfer
F. Incropera (1981)
10.1001/ARCHOPHT.1989.01070020438050
Transscleral iontophoresis of dexamethasone.
T. Lam (1989)
10.1016/0002-9394(56)90360-9
Ocular penetration of antibiotics by iontophoresis.
I. Z. Fielding (1956)
10.1177/019262339902700507
Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration
J. Mordenti (1999)
10.1016/S0002-9440(10)65044-4
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).
K. Miyamoto (2000)
Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.
R. Grossman (1990)
10.1016/S0002-9394(14)73642-6
Transscleral iontophoresis of foscarnet.
D. Sarraf (1993)
10.1089/JOP.1985.1.363
Trans-scleral iontophoresis of gentamicin.
N. Burstein (1985)
Transscleral delivery of bioactive protein to the choroid and retina.
J. Ambati (2000)
10.1089/JOP.1988.4.153
Transscleral and transcorneal iontophoresis of vancomycin in rabbit eyes.
T. Y. Choi (1988)
10.1016/S0161-6420(86)33780-1
Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit.
M. Barza (1986)
10.1089/JOP.1998.14.273
Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye.
N. Unlu (1998)
10.1089/JOP.1995.11.183
Ocular toxicity of iontophoretic foscarnet in rabbits.
M. Yoshizumi (1995)
10.1002/JPS.2600760802
Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.
I. Ahmed (1987)
10.1016/S0002-9394(14)70131-X
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
O. Weijtens (1997)
10.1016/0014-4835(84)90053-8
Characterization of collagen from normal human sclera.
F. Keeley (1984)
Ultrastructure of the extracellular matrix of bovine dura mater, optic nerve sheath and sclera.
M. Raspanti (1992)
10.1016/S0002-9394(99)00239-1
A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
M. Kamei (1999)
10.1016/0306-4522(96)00303-X
Diffusion of albumins in rat cortical slices and relevance to volume transmission
L. Tao (1996)
10.1089/JOP.1998.14.389
Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro.
C. Madhu (1998)
10.1089/JOP.1997.13.529
Determination of ocular toxicity in multiple applications of foscarnet iontophoresis.
M. Yoshizumi (1997)
Diffusion of high molecular weight compounds through sclera.
J. Ambati (2000)
10.1136/bjo.83.12.1370
Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, orl-ornithine
K. Trier (1999)
10.1016/S0014-4835(64)80033-6
THE DRAINAGE OF ALBUMIN FROM THE UVEA.
A. Bill (1964)
10.1016/S0002-9394(42)92865-4
Sulfadiazine Iontophoresis in Pyocyaneus Infection of Rabbit Cornea
L. Sallmann (1942)
Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices.
H. Wessel (1997)
10.1007/BF00170699
A histopathologic study of retinal lesions inflicted by transscleral iontophoresis
T. Lam (2004)
The effect of intraocular pressure on human and rabbit scleral permeability.
D. E. Rudnick (1999)
10.3109/10611869509059212
Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.
H. Sasaki (1995)
10.1038/eye.1998.102
Glycoproteins of trabecular meshwork, cornea and sclera
S. Chapman (1998)
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
T. Olsen (1995)
The three-dimensional organization of collagen fibrils in the human cornea and sclera.
Y. Komai (1991)
10.1001/ARCHOPHT.1965.00970040250024
MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA.
A. Bill (1965)
10.3109/02713689508998399
Atomic force microscopy of the cornea and sclera.
N. Fullwood (1995)
10.3109/02713689008997579
Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
D. Chien (1990)
Enhanced FGF-2 movement through human sclera after exposure to latanoprost.
M. Aihara (2001)
10.1002/AIC.690440123
Fiber matrix model of sclera and corneal stroma for drug delivery to the eye
A. Edwards (1998)
10.1016/S0002-9394(99)80096-8
Human sclera: thickness and surface area.
T. Olsen (1998)
10.1093/OXFORDJOURNALS.JMICRO.A051203
Immunoelectron microscopic localization of decorin in aged human corneal and scleral stroma.
S. Kimura (1995)



This paper is referenced by
10.1089/jop.2007.0110
Fibrin sealant for retinoblastoma: where are we?
Nancy E Martin (2008)
10.1007/s11095-016-1940-2
Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy
L. Hirvonen (2016)
10.1016/J.IJHEATMASSTRANSFER.2012.05.060
Effect of choroidal blood flow on transscleral retinal drug delivery using a porous medium model
A. Narasimhan (2012)
10.1016/j.drudis.2010.12.004
Drug delivery to the posterior segment of the eye.
T. R. Thrimawithana (2011)
10.1016/J.EXER.2005.10.029
P-Glycoprotein expression in human retinal pigment epithelium cell lines.
P. Constable (2006)
Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability
S. Nicoli (2009)
10.1016/j.ejpb.2019.04.016
Delivery of ionic molecules to anterior chamber by iontophoretic contact lenses.
K. Christopher (2019)
10.1002/adhm.201400114
A platform for controlled dual-drug delivery to the retina: protective effects against light-induced retinal damage in rats.
Nobuhiro Nagai (2014)
10.1517/17425241003663236
Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes
A. Amrite (2010)
10.1097/00004397-200404430-00007
Ocular Delivery of Angiostatic Agents
M. Lu (2004)
10.1016/j.ophtha.2011.02.007
Transscleral diffusion of triamcinolone.
Khalil Ghasemi Falavarjani (2011)
Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration
Thilini R Thrimawithana (2011)
10.1590/S0004-27492010000300018
Farmacologia ocular aplicada no tratamento de doenças do vítreo, retina e coróide
P. Filho (2010)
10.1167/IOVS.02-0791
Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.
U. Kompella (2003)
10.1080/02713680590934102
Systemic and Periocular Deliveries of Plasminogen Kringle 5 Reduce Vascular Leakage in Rat Models of Oxygen-Induced Retinopathy and Diabetes
S. Zhang (2005)
10.1007/978-1-59745-047-8_21
Noninvasive Delivery of DNA Into the Eye
J. Nickerson (2006)
10.1691/PH.2008.7322
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
T. Loftsson (2008)
10.3390/pharmaceutics4010212
Evaluation of Tissue Interactions with Mechanical Elements of a Transscleral Drug Delivery Device
S. J. Cohen (2012)
Chapter 2 Design , Development and Evaluation of Nanoparticulate Based Carrier Systems for Ocular Drug delivery
(2015)
10.1016/j.survophthal.2019.08.002
A Review of Aqueous Outflow Resistance and its Relevance to Micro-invasive Glaucoma Surgery.
N. Andrew (2019)
10.3109/10717544.2014.919543
A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system
Z. Huang (2016)
10.1016/J.OHC.2006.05.001
Molecular biology of choroidal neovascularization.
M. Lu (2006)
10.1016/j.jconrel.2014.05.031
Nanotherapy for posterior eye diseases.
I. P. Kaur (2014)
10.1111/j.1755-3768.2012.02557.x
Diffusion of macromolecules through sclera
H. Miao (2013)
10.1167/IOVS.04-1414
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
L. P. Cruysberg (2005)
Farmacocinética, biodisponibilidad y tolerancia ocular de memantina en conejos: Aportaciones al análisis de una nueva formulación oftálmica a base de nanopartículas
E. Calvo (2013)
10.1096/fj.05-4737fje
Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF‐α soluble receptor in uveitis
C. Bloquel (2006)
10.1016/j.ijpharm.2019.118458
Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
Nobuhiro Nagai (2019)
10.1016/J.ADDR.2005.09.005
Intraocular sustained drug delivery using implantable polymeric devices.
T. Yasukawa (2005)
10.1167/iovs.15-16998
Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic Rats.
H. Imai (2015)
10.1201/B12950-10
Barriers to Transscleral Drug Delivery to the Retina
A. Almazan (2012)
10.1517/17425247.3.2.261
Drug delivery from ocular implants
T. Yasukawa (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar